Jpmorgan Chase & Co »

Sarepta Therapeutics Inc. cmn shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Sarepta Therapeutics Inc. cmn shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Sarepta Therapeutics Inc. cmn

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc. cmn held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc. cmn by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $61M 633k 96.43
2023-09-30 $80M 662k 121.22
2023-06-30 $893k 7.8k 114.52
2023-03-31 $52M 374k 137.83
2022-12-31 $36M 278k 129.58
2022-03-31 $3.9M 50k 78.12
2021-12-31 $36M 404k 90.05
2020-12-31 $5.1M 30k 170.50
2020-09-30 $1.8M 13k 141.28
2019-12-31 $19M 144k 129.04
2019-09-30 $5.6M 75k 75.31
2019-06-30 $48M 370k 129.76
2019-03-31 $26M 219k 119.19
2018-12-31 $2.9M 27k 109.15
2018-09-30 $7.1M 44k 161.50
2018-06-30 $5.9M 45k 132.18
2017-12-31 $4.7M 85k 55.64
2016-12-31 $549k 20k 27.45